You are viewing an incomplete version of our website. Please click to reload the website as full version.

anti-Lymphocyte Antigen 9 (LY9) Antikörper

LY9 belongs to the SLAM family of immunomodulatory receptors (see SLAMF1\; MIM 603492) and interacts with the adaptor molecule SAP (SH2D1A\; MIM 300490) (Graham et al., 2006 [PubMed 16365421]).[supplied by OMIM, Mar 2008].. Zusätzlich bieten wir Ihnen LY9 Proteine (16) und LY9 Kits (6) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
LY9 4063 Q9HBG7
LY9 17085 Q01965
LY9 289227  
Direkt bei antikoerper-online bestellen
  • +49 (0)241 95 163 153
  • +49 (0)241 95 163 155
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-LY9 Antikörper auf antikoerper-online.de

Showing 10 out of 121 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Anbieter Lieferzeit Preis Details
Human Maus PE FACS Staining of human peripheral blood lymphocytes with MOUSE ANTI HUMAN CD229 : RPE (ABIN119625). 100 Tests Anmelden zum Anzeigen 8 bis 10 Tage
627,00 €
Details
Human Kaninchen Unkonjugiert EIA, WB Western blot analysis of SLAMF3 / CD229 in 293 cell lysate with SLAMF3 antibody at (A) 1 and (B) 2 μg/ml. 0.1 mg Anmelden zum Anzeigen 8 bis 10 Tage
357,50 €
Details
Human Maus Unkonjugiert FACS, IP ABIN119621 staining of human peripheral blood lymphocytes, visualised with rabbit anti-mouse IgG: FITC (ABIN121364). 1 mg Anmelden zum Anzeigen 8 bis 10 Tage
1.111,00 €
Details
Human Maus FITC FACS   0.1 mg Anmelden zum Anzeigen 8 bis 10 Tage
506,00 €
Details
Human Maus PE FACS Detection of CD229/SLAMF3 in Human PBMCs by Flow Cytometry. Human peripheral blood mononuclear cells (PBMCs) were stained with Mouse Anti-Human CD3 epsilon APC-conjugated Monoclonal Antibody. 100 Tests Anmelden zum Anzeigen 3 bis 4 Tage
350,00 €
Details
Maus Hamster Biotin FACS, IF, IHC 50 μg Anmelden zum Anzeigen 6 bis 8 Tage
72,47 €
Details
Maus Hamster PE FACS 50 μg Anmelden zum Anzeigen 6 bis 8 Tage
103,53 €
Details
Human Kaninchen Unkonjugiert ELISA, IHC (p), WB Immunohistochemistry (IHC) analysis of paraffin-embedded Human Prostate Cancer, antibody was diluted at 1:100. 100 μL Anmelden zum Anzeigen 13 Days
154,33 €
Details
Human Maus PE FACS, ICFC 100 Tests Anmelden zum Anzeigen 6 bis 8 Tage
248,47 €
Details
Human Kaninchen Unkonjugiert WB Western blot analysis of CD229 expression in HepG2 (A), Raw264.7 (B), H9C2 (C) whole cell lysates. 200 μL Anmelden zum Anzeigen 7 bis 8 Tage
464,29 €
Details

LY9 Antikörper nach Reaktivität, Anwendung, Klonalität and Konjugat

Attribute Applikationen Wirt Klonalität Konjugat
Human , , , ,
, ,
,
, , , , , , , , , , , , , ,
Mouse (Murine) , , , ,
, , ,
,
, , , , , , , , , , , , , ,
Rat (Rattus) ,


, , , , , , , , , , ,

Am meisten referenzierte anti-LY9 Antikörper

  1. Human Monoclonal LY9 Primary Antibody für FACS, ICFC - ABIN2663194 : Graham, Bell, McCausland, Huntoon, van Deursen, Faubion, Crotty, McKean: Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice. in Journal of immunology (Baltimore, Md. : 1950) 2005 (PubMed)
    Zeige alle 5 Referenzen für ABIN2663194

  2. Mouse (Murine) Monoclonal LY9 Primary Antibody für FACS, IF - ABIN2660997 : Martín, Del Valle, Saborit, Engel: Identification of Grb2 as a novel binding partner of the signaling lymphocytic activation molecule-associated protein binding receptor CD229. in Journal of immunology (Baltimore, Md. : 1950) 2005 (PubMed)
    Zeige alle 5 Referenzen für ABIN2660997

  3. Mouse (Murine) Monoclonal LY9 Primary Antibody für FACS - ABIN2663193 : Romero, Zapater, Calvo, Kalko, de la Fuente, Tovar, Ockeloen, Pizcueta, Engel: CD229 (Ly9) lymphocyte cell surface receptor interacts homophilically through its N-terminal domain and relocalizes to the immunological synapse. in Journal of immunology (Baltimore, Md. : 1950) 2005 (PubMed)
    Zeige alle 5 Referenzen für ABIN2663193

  4. Human Monoclonal LY9 Primary Antibody für FACS - ABIN119625 : Abazov, Abbott, Abolins, Acharya, Adams, Adams, Agelou, Agram, Ahn, Ahsan, Alexeev, Alkhazov, Alton, Alverson, Alves, Anastasoaie, Andeen, Anderson, Andrieu, Anzelc, Arnoud, Arov, Askew, Asman, Jesus, Atramentov, Autermann, Avila, Ay, Badaud, Baden, Bagby: Measurement of the Bs(0) lifetime using semileptonic decays. in Physical review letters 2007 (PubMed)
    Zeige alle 3 Referenzen für ABIN119625

  5. Human Polyclonal LY9 Primary Antibody für EIA, WB - ABIN783456 : Del Valle, Engel, Martín: The cell surface expression of SAP-binding receptor CD229 is regulated via its interaction with clathrin-associated adaptor complex 2 (AP-2). in The Journal of biological chemistry 2003 (PubMed)
    Zeige alle 3 Referenzen für ABIN783456

  6. Human Monoclonal LY9 Primary Antibody für FACS - ABIN119623 : de la Fuente, Tovar, Villamor, Zapater, Pizcueta, Campo, Bosch, Engel: Molecular characterization and expression of a novel human leukocyte cell-surface marker homologous to mouse Ly-9. in Blood 2001 (PubMed)
    Zeige alle 2 Referenzen für ABIN119623

  7. Human Monoclonal LY9 Primary Antibody für FACS - ABIN4897608 : Atanackovic, Panse, Hildebrandt, Jadczak, Kobold, Cao, Templin, Meyer, Reinhard, Bartels, Lajmi, Zander, Marx, Bokemeyer, Kröger: Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma. in Haematologica 2011 (PubMed)

Weitere Antikörper gegen LY9 Interaktionspartner

Human Lymphocyte Antigen 9 (LY9) Interaktionspartner

  1. the results presented here suggest that the tumor suppressor potential of SLAMF3 occurs through activation of Retinoblastoma protein that represses PLK1 (zeige PLK1 Antikörper).

  2. study showed CD229 is overexpressed on the malignant plasma cells of patients across all types of plasma cell dyscrasias including multiple myeloma; CD229 is also expressed on the surface of a fraction of cells carrying the phenotype of chemotherapy-resistant and myeloma-propagating cells within the patients' bone marrow

  3. the Val602 variant of the non-synonymous single nucleotide polymorphism (SNP) rs509749 in the SLAM (zeige SLAMF1 Antikörper) family member CD229 (Ly9, SLAMF3) has a two-fold lower affinity compared with the SLE-associated Met602 variant for the small adaptor protein SAP (zeige APCS Antikörper)

  4. CD229 Expression on Bone Marrow Plasma Cells from Patients with Multiple Myeloma and Monoclonal Gammopathies of Uncertain Significance.

  5. Results revealed that SLAMF3 plays a role during hepatitis C virus entry, likely by enhancing entry of viral particle within hepatocytes.

  6. SLAMF3 is an inhibitor of hepatocellular carcinoma cell proliferation and tumor progression.

  7. These results suggest a role for CD319 (zeige SLAMF7 Antikörper) and CD229 in the systemic lupus erythematosus disease process.

  8. Data indicate that the dominance of the SLAMF3/SLAMF6 (zeige SLAMF6 Antikörper) pathway in inducing IL-17A (zeige IL17A Antikörper) production can be attributed to an increased nuclear abundance and recruitment of RORgammat to the IL17A (zeige IL17A Antikörper) promoter.

  9. SLAMF3 and SLAMF6 (zeige SLAMF6 Antikörper) T cell surface expression and IL-17 (zeige IL17A Antikörper) levels significantly correlate with disease activity in systemic lupus erythematosus patients

  10. CD229 is specifically over-expressed on myeloma cells including their clonogenic precursors and contributes to their malignant phenotype.

Mouse (Murine) Lymphocyte Antigen 9 (LY9) Interaktionspartner

  1. SLAMF3 is an inhibitor of hepatocellular carcinoma cell proliferation and tumor progression.

  2. Ly9/CD229 cell surface receptor emerges as a uniquely important element for modulating innate T cell function, acting as an inhibitory molecule that regulates invariant natural killer (NK)T cell development and innate-like CD8 (zeige CD8A Antikörper) T cell expansion.

  3. Data show that defective tolerance was observed only in Fcgr2b (zeige FCGR2B Antikörper)-deficient mice with autoimmune-type Slam (zeige SLAMF1 Antikörper) family genes, indicating that epistatic effects of both genes are involved.

  4. mouse novel Ly9 (zeige SLAMF7 Antikörper) is a new member of the expanding CD150 (zeige SLAMF1 Antikörper) family of cell surface receptors

  5. CD229 is a self-ligand, interacting through its N-terminal V-like domain which contains three amino acid residues critical for the homophilic binding interaction.

  6. CD229 is a pan (zeige SUPT6H Antikörper)-lymphocyte marker and indicate that mAbs against CD229 are able to down-modulate T-cell activation.

LY9 Antigen-Profil

Protein Überblick

LY9 belongs to the SLAM family of immunomodulatory receptors (see SLAMF1\; MIM 603492) and interacts with the adaptor molecule SAP (SH2D1A\; MIM 300490) (Graham et al., 2006

Genbezeichner und Symbole assoziert mit LY9

  • lymphocyte antigen 9 (LY9) Antikörper
  • lymphocyte antigen 9 (Ly9) Antikörper
  • AI893573 Antikörper
  • CD229 Antikörper
  • hly9 Antikörper
  • Lgp100 Antikörper
  • Ly-9 Antikörper
  • LY9 Antikörper
  • mLY9 Antikörper
  • SLAMF3 Antikörper
  • T100 Antikörper

Bezeichner auf Proteinebene für LY9

lymphocyte antigen 9 , T-lymphocyte surface antigen Ly-9 , T-lymphocyte surface antigen Ly-9-like , t-lymphocyte surface antigen Ly-9-like , SLAM family member 3 , cell surface molecule Ly-9 , signaling lymphocytic activation molecule 3

GENE ID SPEZIES
457438 Pan troglodytes
488643 Canis lupus familiaris
528926 Bos taurus
100155269 Sus scrofa
100406059 Callithrix jacchus
100437582 Pongo abelii
100465450 Ailuropoda melanoleuca
4063 Homo sapiens
17085 Mus musculus
289227 Rattus norvegicus
Ausgewählte Anbieter für anti-LY9 (LY9) Antikörper
Haben Sie etwas anderes gesucht?